Arkolith/Insider Trading/DNLI/Form 4

Watts Ryan J.

President and CEO, DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Oct 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 18, 2024Option exercise(M)40K$0.68$27K276K
Oct 18, 2024Sell(S)40K$27.69$1.1M236K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 18, 2024Option exercise(M)40K—$01.1M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000206) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML